Solifenacin treatment in men with overactive bladder: effects on symptoms and patient-reported outcomes

Author： Kaplan Steven A. Goldfischer Evan R. Steers William D. Gittelman Marc Andoh Masakazu Forero-Schwanhaeuser Sergio

Publisher： Informa Healthcare

ISSN： 1473-0790

Source： The Aging Male, Vol.13, Iss.2, 2010-06, pp. : 100-107

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Is antimuscarinic treatment of overactive bladder symptoms effective and safe in elderly patients?

By Michel Martin C

Aging Health, Vol. 6, Iss. 5, 2010-10 ,pp. : 595-597

Future Medicine

Access to resources Recommend Favorite

Darifenacin for the treatment of overactive bladder

By Blok Bertil FM Corcos Jacques

Aging Health, Vol. 3, Iss. 2, 2007-04 ,pp. : 143-147

Future Medicine

Access to resources Recommend Favorite

Socioeconomic differences in patient-reported outcomes after a hip or knee replacement in the English National Health Service

By Neuburger J. Hutchings A. Black N. van der Meulen J.H.

Journal of Public Health, Vol. 35, Iss. 1, 2013-03 ,pp. : 115-124

Oxford University Press

Access to resources Recommend Favorite

Fesoterodine: a new antimuscarinic for overactive bladder

By Guay David RP

Aging Health, Vol. 5, Iss. 5, 2009-10 ,pp. : 599-613

Future Medicine

Access to resources Recommend Favorite

The effect of testosterone therapy on lower urinary tract symptoms/bladder and sexual functions in men with symptomatic late-onset hypogonadism

By KarazindiyanoĞlu Sinan Cayan Selahittin

The Aging Male, Vol. 11, Iss. 3, 2008-09 ,pp. : 146-149

Informa Healthcare

Access to resources Recommend Favorite